SC 13D/A

AMENDMENT NO. 14 TO THE SCHEDULE 13D

Company: Enveric Biosciences, Inc.
Filed: November 16, 2018
Accession Number: 0000921895-18-003084

View Document ↗ View on SEC.gov ↗